Risk factors for revision due to infection after primary total hip arthroplasty: A population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry by Pedersen, Alma B et al.
542  Acta Orthopaedica 2010; 81 (5): 542–547
Risk factors for revision due to infection after primary total 
hip arthroplasty
A population-based study of 80,756 primary procedures in the Danish Hip 
Arthroplasty Registry 
Alma B Pedersen1, Jens E Svendsson2, Søren P Johnsen1, Anders Riis1, and Søren Overgaard2
1Department of Clinical Epidemiology, Aarhus University Hospital, Århus; 2Department of Orthopaedic Surgery and Traumatology, Clinical Institute, 
Odense University Hospital, University of Southern Denmark, Odense, Denmark 
Correspondence ABP: abp@dce.au.dk
Submitted 09-11-17-. Accepted 10-05-24
Open Access - This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, 
distribution, and reproduction in any medium, provided the source is credited.
DOI 
Background and purpose   There has been a limited amount 
of research on risk factors for revision due to infection follow-
ing total hip arthroplasty (THA), probably due to low absolute 
numbers of revisions. We therefore studied patient- and surgery-
related risk factors for revision due to infection after primary 
THA in a population-based setting.
Materials and methods   Using the Danish Hip Arthroplasty 
Registry, we identified 80,756 primary THAs performed in Den-
mark between Jan 1, 1995 and Dec 31, 2008. We used Cox regres-
sion analysis to compute crude and adjusted relative risk (RR) of 
revision due to infection. Revision was defined as extraction or 
exchange of any component due to infection. The median follow-
up time was 5 (0–14) years.
Results   597 primary THAs (0.7%) were revised due to infec-
tion. Males, patients with any co-morbidity, patients operated due 
to non-traumatic avascular femoral head necrosis, and patients 
with long duration of surgery had an increased RR of revision 
due to infection within the total follow-up time. A tendency of 
increased RR of revision was found for patients who had received 
cemented THA without antibiotic and hybrid THA relative to 
patients with cementless implants. Hip diagnosis and fixation 
technique were not associated with risk of revision due to infec-
tion within 1 year of surgery (short-term risk). 
Interpretation   We identified several categories of THA 
patients who had a higher risk of revision due to infection. Fur-
ther research is required to explain the mechanism underlying 
this increased risk. More attention should be paid by clinicians to 
infection prevention strategies in patients with THA, particularly 
those with increased risk. 
 
As with any other surgical operation, serious complications 
in patients undergoing total hip arthroplasty (THA) include 
infections. Most infections stem either from contamination 
in the operating room or from later hematogenous spread. 
Deep infection is the third most common cause of revision of 
THAs in Denmark (DHR Annual repport 2008). In the last 2 
decades, advances in theater design and the prophylactic use 
of antibiotics, either systemically or incorporated in cement, 
have substantially reduced the incidence of infection after 
hip replacement (Zimmerli and Ochsner 2003, Ridgeway et 
al. 2005, Phillips et al. 2006). However, recent studies in the 
United States and Norway have found increasing infection 
rates (Dale et al. 2009 , Kurtz et al. 2010). 
Research on risk factors for revision due to infection fol-
lowing THA has been limited, probably due to low absolute 
numbers of revisions. However, in the last few years several 
reports have suggested that some patient- and surgery-related 
factors may play a role (Furnes et al. 2001, Saleh et al. 2002, 
Ridgeway et al. 2005, Engesaeter et al. 2006, Bongartz et al. 
2008, Pulido et al. 2008, Dale et al. 2009, Hooper et al. 2009, 
Ong et al. 2009). Comparison of these studies is difficult due 
to different inclusion criteria for the study population and dif-
ferent definitions of infection, sometimes including both joint 
infections and superficial infections, or infections in general. 
We studied only the infections that were followed by revision 
of the implant.
For this reason, we conducted a nationwide follow-up study 
using the Danish Hip Arthroplasty Registry to examine poten-
tial patient- and surgery-related risk factors for revision due 
to infection.
Material and methods
Data sources and settings
We designed the study as a population-based follow-up study 
using data from the prospective, nationwide Danish medical 
registries. Since 1968, all Danish citizens have been assigned 
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mitting unambiguous linkage of records in different data-
bases (Pedersen et al. 2006). The Danish National Registry 
of Patients (NRP) holds information about all contacts with 
public hospitals in Denmark since 1977, including dates of 
all admissions and discharges and with up to 20 diagnoses for 
each admission. The diagnoses are classified according to the 
International Classification of Diseases (eighth edition (ICD-
8) up to 1993 and the tenth edition (ICD-10) after that). 
Study population
The Danish Hip Arthroplasty Registry (DHR) was established 
on Jan 1, 1995 and is a nationwide clinical database of all pri-
mary THAs and revisions performed in Denmark. Registration 
in the DHR is compulsory. All orthopedics departments per-
forming total hip replacement, including private hospitals (n = 
52), report pre- and peroperative data from both primary and 
revision surgery to the registry using a standard registration 
form. We identified all primary THA procedures in the DHR 
(n = 80,756) performed from Jan 1, 1995 to Dec 31, 2008. Of 
these, 12,234 (15%) were bilateral procedures (including 758 
one-stage and 11,476 two-stage procedures). 
Risk factors 
As possible patient-related risk factors, we considered age 
(10–59 years, 60–69 years, 70–79 years, and 80+ years), sex, 
indication for primary THA (primary osteoarthritis (OA), 
sequelae from trauma (including both THA due to acute proxi-
mal femoral fracture and sequelae from the same one), non-
traumatic avascular femoral head necrosis (AVN), inflamma-
tory arthritis, and other hip diseases), and previous surgery on 
the same hip. Based on the NRP, for each patient we assessed 
the co-morbidity level using the Charlson co-morbidity index 
(Charlson et al. 1987), which was originally developed and 
validated for the prediction of short- and long-term mortality 
in patients admitted to a department of internal medicine (Deyo 
et al. 1992) and adapted for use with hospital discharge registry 
databases (De Groot et al. 2003). The Charlson index includes 
19 major disease categories extracted from the NRP using all 
primary and secondary discharge ICD-8 and ICD-10 diagno-
ses for all hospitalizations and outpatient visits from January 
1, 1977 to the date of primary THA. A weight of 1, 2, 3, or 
6 points is assigned to discharge from each co-morbidity cat-
egory and the index score is the sum of these weights. We clas-
sified the patients according to 2 levels of co-morbidity: low 
(score 0 at the time of surgery) and medium/high (score ≥ 1). 
Data regarding fixation technique (cemented with antibi-
otics, cemented without antibiotics, cementless, or hybrid), 
duration of surgery (less than 60 min, 61–90 min, 91–120 
min, or more than 120 min), type of anesthesia (general or 
regional), operating theater (conventional or laminar-flow 
ventilation) and ossification prophylaxis with NSAID were 
considered as prosthetic and surgery- related risk factors. Fur-
thermore, calendar year of surgery was investigated as a risk 
factor. Information on all these risk factors was obtained from 
the DHR. Different types of previous surgery and systemic 
antibiotics were not studied as risk factors due to the insuf-
ficient sample size and low number of revisions. 
Outcome
The outcome was time to failure, i.e. first revision due to 
infection. Revision was defined as a new surgical procedure 
involving partial or complete removal or exchange of any 
of the components. Infection was diagnosed by the surgeon 
reporting to the registry. 
Statistics
The follow-up period started on the day of primary THA and 
ended on the day of revision, death, emigration, or Jan 1, 
2009, whichever came first. We used Cox’s regression analy-
sis to examine the association between possible risk factors 
and risk of revision due to infection We estimated hazard ratio 
as a measure of relative risk (RR) with 95% confidence inter-
val (CI) for each risk factor, crude and mutually adjusted for 
all risk factors. We studied the revision risk during the entire 
follow-up time period, and also the revision risk within 1 year 
of THA surgery (short-term risk). Bilateral THAs were treated 
as 2 independent observations according to previous findings 
of no difference in RR estimates irrespective of whether the 
bilateral THA was included or excluded from the analysis (Lie 
et al. 2004). 
All analyses were performed using a statistical software 
package (SAS version 9.1.3; SAS Institute Inc, Cary, NC). 
Assumption of proportionality of the Cox regression model was 
assessed graphically for each risk factor and found appropriate. 
The study was approved by the Danish National Board of 
Health and the Danish Data Protection Agency (J. no. 2007-
41-0720). 
Results
We identified 80,756 primary THAs for the study in the DHR 
during the study period, which had been performed on 74,639 
patients. Thus 6,117 patients (corresponding to 12,234 THAs) 
received THAs in both hips. 46,831 THAs (58%) were in 
females, 28,729 THAs (36%) had been associated with prior 
co-morbidities, and 63,318 THAs (78%) were operated due to 
primary OA. During the maximum follow-up time of 14 years 
(median 4.6 years), 597 primary THAs (0.7%) were revised 
due to infection: 149 (25%) involved total exchange of the 
prosthesis, 146 (24%) involved partial exchange of the pros-
thesis, and 302 (50%) involved total removal of the prosthesis. 
Patient-related risk factors for revision due to infec-
tion (Table 1)
Male sex was associated with an increased adjusted RR of revi-
sion, whereas age had no influence on the risk. Patients with 
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of revision compared to patients with primary OA, whereas 
patients with inflammatory arthritis and other hip diagnoses 
had the same risk as OA patients. There tended to be more 
infections in patients with proximal femoral fracture. The 
presence of any co-morbidity at the time of surgery was found 
to be a predictor of revision. Previous surgery on the same hip 
did not affect the revision risk. Among 9,321 patients with pre-
vious surgery on the same hip, three-quarters were registered 
as osteosynthesis and the rest as hemiarthroplasty, surgery due 
to acetabulum fracture, proximal femoral osteotomi, or other 
surgery. The material was too small to study the risk of revi-
sion due to infection separately for different types of previous 
operations.
Prosthetic concept and surgery-related risk factors 
for revision due to infection (Table 2)
Patients with hybrid THA and cemented THA without anti-
biotics had an increased adjusted RR of revision compared to 
patients operated with cementless THA. There was an asso-
ciation between cemented THA with antibiotics and elevated 
risk of revision, but this did not reach statistical significance. 
Surgery exceeding 2 h was associated with an elevated risk 
of revision due to infection relative to patients operated for 
less than 1 h. We found no association between ossification 
prophylaxis, type of anesthesia, or type of operating theater on 
the one hand and risk of revision on the other. 
Compared to the period 1995–1997, the risk of revision was 
similar for patients operated in 1998–2002 (adjusted RR = 
0.94, CI: 0.74–1.18) and in 2003–2005 (adjusted RR = 0.85, 
CI: 0.63–1.13). In contrast, the risk of revision was 1.45 times 
higher (CI: 1.07–1.96) for patients operated in 2006–2008 
compared to those operated in 1995–1997. 
Risk of revision due to infection within 1 year of THA 
surgery: subanalyses
During the first year after THA surgery, male sex, any co-mor-
bidity, and the period 2006–2008 (as compared to 1995–1997) 
were risk factors for revision similar to those found during 
the entire follow-up period. AVN hip diagnosis and fixation 
technique, which were risk factors during the entire follow-
up period, were not risk factors during the first year (data not 
shown). 
Discussion
In this observational, nationwide population-based study of 
80,756 THA procedures, 0.7% were revised due to infection. 
We identified several patient-, prosthesis-, and surgery-related 
risk factors for revision that might be considered with a view 
to improving infection strategies. 
The strengths of our study include its population-based, pro-
spective design with a large sample size and complete follow-
up. Furthermore, the validity of our findings also depends on 
accurate coding of data in the DHR, as well as completeness 
of registration of both primary THA and revision cases in the 
DHR. We have previously documented that overall, there is a 
high validity of data in the DHR and a completeness of reg-
istration of approximately 94% (Pedersen et al. 2004). Due 
to the prospective registration of data in DHR, it is highly 
Table 1. Patient-related risk factors for revision due to infection following primary total hip arthroplasty 
during the maximum follow-up time of 14 years
  Patients (n)  Revision due to   Crude RR  Adjusted RR a 
   infection (n/%)  (95% CI)  (95% CI)
Sex            
  Female  46,831  293 (0.63%)  1 (ref.)   1 (ref.)
  Male  33,925  304 (0.90%)  1.46 (1.24–1.71)  1.53 (1.30–1.80)
Age groups (years)            
    0–59  16,537  126 (0.76%)  1 (ref.)   1 (ref.) 
  60–69  24,626  183 (0.74%)  1.01 (0.80–1.26)   0.98 (0.77–1.24)
  70–79   27,422  210 (0.77%)  1.06 (0.85–1.32)  0.97 (0.75–1.26)
  80+  12,171    78 (0.64%)  0.97 (0.73–1.29)  0.86 (0.63–1.19)
Charlson co-mobidity index       
  Index, low (0)  52,027  356 (0.68%)  1 (ref.)   1 (ref.) 
  Index, medium to high (1+)  28,729  241 (0.84%)  1.38 (1.17–1.63)  1.30 (1.09–1.54)
Diagnosis for primary THA       
  Primary osteoarthrosis   63,318  443 (0.70%)  1 (ref.)   1 (ref.) 
  Proximal femoral fracture     9,380    88 (0.94%)  1.51 (1.20–1.90)   1.46 (0.99–2.17)
  Non-traumatic AVN     2,148    28 (1.30%)  1.85 (1.26–2.71)  1.70 (1.15–2.53)
  Inflammatory arthritis     2,067    21 (1.02%)  1.33 (0.86–2.06)  1.19 (0.76–1.88)
  Other diagnoses     3,843    17 (0.44%)  0.63 (0.39–1.03)  0.63 (0.38–1.04)
Previous surgery to the same hip       
  No  71,435    513 (0.72%)  1 (ref.)  1 (ref.)
  Yes    9,321      84 (0.90%)  1.32 (1.05–1.67)  0.95 (0.64–1.41)
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unlikely that any missing registrations of the primary THA are 
systemtically linked to later revision status. Thus, lack of reg-
istration of revisions may cause underestimation of the overall 
revision rate in our study, but it would not have biased rela-
tive risk estimates substantially. In addition, we believe that 
nowadays most of the cases with acute infection will either 
have revision surgery or a debridement with exchange of some 
components (liner and/or head). 
Several limitations of the study must also be pointed out. 
Lack of registration with the NRP and inconsistent coding 
practices may have influenced estimation of the Charlson co-
morbidity index, and thereby introduced residual confound-
ing in multivariate analyses. Misclassification of the Charlson 
index may lead to information bias if it is related to revision. 
However, the latest validation study of the diagnoses included 
in the Charlson co-morbidity index, as ascertained from the 
NRP, showed a high quality of hospital discharge data for all 
19 diagnoses (Thygesen et al. 2009). 
We were able to adjust for a number of possible confound-
ers. However, some other confounders related to risk factors 
and infection rate may have influenced our risk estimates, e.g. 
patient weight, height, smoking, medication at follow-up, and 
alcohol intake. This information was not available in our data-
set. Finally, we should bear in mind that the absolute risk of 
revision is low when interpreting relative risks. 
Patient-related risk factors
A few other studies (Malchau et al. 2002, Dale et al. 2009, 
Jämsen et al. 2009, Ong et al. 2009, Kurtz et al. 2010) have 
also found that males have a higher risk of long-term total hip 
and knee arthroplasty failure due to infection. THA in males 
often means a greater degree of surgical trauma and tissue 
necrosis than in females. It is possible that male patients have 
a greater chance of being referred to an orthopedic specialist 
due to infection (Franks and Clancy 1997) or that surgeons 
have lower thresholds for males than for females when decid-
ing on indications for revision (Hawker et al. 2000). Our find-
ing of increased infection risk in THAs with a Charlson score 
of ≥ 1 is not surprising, since a number of diseases included 
in the Charlson co-morbidity index such as stroke, liver dis-
ease, diabetes, and cancer are known to be associated with 
poor bone quality and increased mortality rate (Arikoski et al. 
1999, Levendoglu et al. 2004, Schwartz et al. 2005). Kurtz et 
al. (2009) found that the presence of pre-existing co-morbidity 
in terms of the Charlson index score being ≥ 1 increase the risk 
of prosthetic hip infection (p < 0.0001) and the adjusted RR 
for a Charlson score of 5+ as compared to a score of 0 was 2.2. 
Regarding primary diagnosis, AVN was a strong predictor 
of long-term risk of THA infection, but not for short-term 
risk. Similar failure rates in general between AVN patients 
and standard THA patients have been reported (Myers et al. 
2010). However, revision due to infection has been found 
to be commoner in AVN patients than in OA patients (Hav- (Hav-
elin et al. 2000, Malchau et al. 2002, Radl et al. 2005). The 
increased long-term risk of infection in AVN patients may 
be due to underlying risk factors present in the AVN popula-
tion but not in the OA population, such as corticosteroid ther-
apy, trauma, renal disease, and alcohol consumption, which 
together cause 90% of cases (Mont and Hungerford 1995). 
These factors are associated with increased risk of infection, 
and they may thereby introduce the confounding bias in our 
estimates. Unfortunately, there was no information on these 
Table 2. Prosthesis- and surgery-related factors and calendar year of surgery as risk factors for revision 
due to infection following primary total hip arthroplasty during the maximum follow-up time of 14 years
  Patients (n)  Revision due to   Crude RR  Adjusted RR a 
   infection (n/%)  (95% CI)  (95% CI)
Fixation technique 
  Cementless  25,571  132 (0.52%)  1 (ref.)   1 (ref.)
  Cement with antibiotics   25,461  184 (0.72%)  1.25 (1.00–1.56)  1.24 (0.94–1.62)
  Cement without antibiotics     9,185    96 (1.05%)  1.38 (1.06–1.81)  1.41 (1.01–1.96)
  Hybrid  20,539  185 (0.90%)  1.47 (1.18–1.84)  1.53 (1.19–1.96)
Duration of surgery (min)     
  ≤ 60  24,511  130 (0.53%)  1 (ref.)  1 (ref.)
  61–90  37,273  283 (0.76%)  1.23 (1.00–1.52)  1.14 (0.91–1.42)
  91–120  13,608  103 (0.76%)  1.22 (0.94–1.58)  1.09 (0.83–1.44)
  121+  5,283    81 (1.51%)  2.29 (1.73–3.02)  2.02 (1.49–2.75)
Ossification prophylactic treatment     
  No prophylaxis  70,993  512 (0.72%)  1 (ref.)  1 (ref.)
  NSAID treatment    9,763    85 (0.87%)  1.04 (0.83–1.31)  1.05 (0.83–1.34)
Type of anesthesia     
  Regional  61,287  427 (0.70%)  1 (ref.)  1 (ref.)
  Universal  19,469  170 (0.87%)  1.22 (1.02–1.46)  1.17 (0.97–1.40)
Operating theater     
  Conventional ventilation    8,333    80 (0.96%)  1 (ref.)  1 (ref.)
  Laminar air flow ventilation  72,423  517 (0.71%)  0.81 (0.64–1.03)  0.90 (0.70–1.14)
a Relative risk mutually adjusted for other factors in Tables 1 and 2, and calendar year of surgery. 546  Acta Orthopaedica 2010; 81 (5): 542–547
factors available in our dataset, or in previously reported stud-
ies. The similar short-term risks of revision due to infection in 
AVN and OA patients may suggest that pre-, peri-, and imme-
diate postoperative care of AVN patients was similar to, if not 
better than, that of OA patients.
Previous studies have reported an increased risk of joint 
infection in hip and knee replacement patients with inflam-
matory arthritis (Bongartz et al. 2008, Jämsen et al. 2009), 
which was not confirmed in our study. A study by Bongartz 
et al. (2008) found a 4 times higher risk of joint infection in 
rheumatoid arthritis patients than in OA patients in a small 
population of 462 hip and knee patients, which introduced 
uncertainty in their estimate with a wide confidence interval. 
In addition, they studied not only revisions due to infection but 
also infections treated nonoperatively conservative, making 
comparison with our estimates difficult. Jämsen et al. (2009) 
used the same outcome as we did and included a large patient 
sample, but the study was based on knee replacements, which 
might have had a different risk of revision than hip replace-
ment patients. Even so, our results agree with the results 
from the latest large registry-based study on hip replacement 
patients (Dale et al. 2009). 
Prosthesis- and surgery-related risk factors 
The increased long-term risk of revision due to infection in 
hybrid and cemented implants than in uncemented ones is in 
accordance with the results from the New Zeeland hip regis-
ter (Hooper et al. 2009). In our study, the risk of infection in 
cemented implants was influenced by high risk in cemented 
implants without antibiotics, as has been reported previously 
(Engesaeter et al. 2006, Hooper et al. 2009, Jämsen et al. 
2009). Thus, in cemented primary THAs, cement with antibi-
otic should be used. Nevertheless, the opposite tendency was 
seen in Norway (Dale et al. 2009), where an increased risk 
of revision due to infection in uncemented implants was seen 
compared to cemented implants with antibiotics. Since liter-
ally all of our THA patients received systemic antibiotic, this 
could not have been the reason for the discrepancy. It has been 
tradition to use uncemented implants in Denmark for many 
years, to a much higher extent than in Norway. Long-term, 
the risk of revision for any reason in uncemented implants has 
been reported to be 1.6 and 2.1 times higher in Norway and 
Sweden, respectively, than in Denmark (Havelin et al. 2009). 
However, the risk of revision due to infection has not yet 
been studied in the Nordic Arthroplasty Register Association 
(NARA). We have no clear explanation for the increased risk 
of long-term revision in hybrid implants, since more than 85% 
of hybrids included cement with antibiotic and all received 
systemic antibiotic. One can speculate that the cement itself 
may be a source of microorganisms (Tunney et al. 2007). 
One interesting finding was that the risk of infection within 
1 year was similar for different fixation techniques, suggest-
ing that the long-term risk of infection may have something 
to do with patient characteristics, the implant brand used, or 
cement-related factors, as mentioned above; this requires fur-
ther study. 
We found an association between long duration of sur-
gery and risk of revision, which agrees with previous find-
ings (Kessler et al. 2003, Smäbrekke et al. 2004, Ong et al. 
2009). Some researchers have suggested that each additional 
minute of operating time leads to a 3% increase in periop-
erative complications (Kessler et al. 2003). Long procedures 
can also increase the risk of blood loss, hematoma formation, 
or venous thromboembolism (Jibodh et al. 2004, Jaffer et al. 
2005). Prolonged procedures may be an indicator of periop-
erative complications, complex surgery, an inexperienced 
surgical team, less than optimal standardization programs, or 
patients’ pre-existing conditions (Strum et al. 2000, Jibodh et 
al. 2004, Jaffer et al. 2005). 
We found no difference between laminar air flow and con-
ventional operating theater conditions, which is in accordance 
with the results of several studies questioning the benefits of 
laminar air flow and which is in line with the idea that deep 
infection has a multifactorial etiology (Friberg et al. 1998, 
Brandt et al. 2008, Dale et al. 2009). 
Both long- and short-term risk of revision due to infection 
increased with later calendar time of surgery, which has also 
been reported recently (Dale et al. 2009). Orthopedic surgeons 
may be more prone to treat implant infection with surgery or 
they may be better at registering deep implant infections now 
than some years ago. In addition, the changes in patient co-
morbidity profiles (for example, increased proportion of THA 
in patients with diabetes and obesity over time) and indica-
tions for surgery (e.g. lower threshold for surgery) may in part 
explain our findings. In the worst case, the true incidence of 
infection has increased in recent years. 
In conclusion, the overall risk of revision due to infection 
following primary THA surgery in Denmark is less than 1%. 
Several factors are associated with increased risk, including 
male sex, co-morbidities, AVN, cement without antibiotic, and 
hybrid THA, as well as long duration of surgery. AVN and 
fixation technique did not increase the risk of infection within 
1 year of surgery. Further research may help to explain the 
mechanism underlying this increased risk of infection, which 
may in turn focus the attention of clinicians on infection pre-
vention strategies. 
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